medigraphic.com
Instituto Nacional de Salud Pública

2021, Number 6

<< Back Next >>

salud publica mex 2021; 63 (6)

Prevalence of diabetes and glycemic control in Mexico: national results from 2018 and 2020

Basto-Abreu A, López-Olmedo N, Rojas-Martínez R, Aguilar-Salinas CA, De la Cruz-Góngora V, Rivera-Dommarco J, Shamah-Levy T, Romero-Martínez M, Barquera S, Villalpando S, Barrientos-Gutiérrez T

Language: English
References: 25
Page: 725-733
PDF size: 305.31 Kb.


ABSTRACT

Objective. To estimate the prevalence of diabetes (diagnosed and undiagnosed), glycemic control in Mexico, and its associated factors. Materials and methods. We used data from Ensanut 2018 (n=12 648) and 2020 (n=2 309). We defined diabetes as fasting glucose ≥126 mg/dl or HbA1c≥6.5% or previously diagnosed; glycemic control was defined as HbA1c‹7%. We fitted Poisson regression models to assess the association between diabetes, glycemic control, and potential associated factors. Results. The total prevalence of diabetes was 16.8% in 2018 and 15.7% in 2020. In 2018, 38% of adults with diabetes were unaware of their disease, while in 2020 this figure was 29%. Glycemic control was observed in 42% of participants in 2018 and 39% in 2020. Longer disease duration was associated with lower glycemic control, while older age, having a diet, and being affiliated to IMSS, Pemex, Sedena, or private healthcare were associated with better control. Conclusion. Mexico is among the countries with the highest diabetes prevalence. A high proportion of adults with diabetes did not have a previous diagnosis, and the proportion with glycemic control is low. Strengthening screening to achieve a timely diagnosis, and improving glycemic control, should be key actions in the management of diabetes.


REFERENCES

  1. Institute for Health Metrics and Evaluation. GBD Compare 2016 [Internet]. University of Washington, 2017 [cited 2017 Mar 12]. Available from: http://ihmeuw.org/3pgz

  2. Rojas-Martínez R, Basto-Abreu A, Aguilar-Salinas CA, Rojas Z-R, Villalpando S, Barrientos-Gutiérrez T. Prevalencia de diabetes por diagnóstico médico previo en México. Salud Publica Mex. 2018;60(3):224-32. https:// doi.org/10.21149/8566

  3. Basto-Abreu A, Barrientos-Gutiérrez T, Rojas-Martínez R, Aguilar-Salinas CA, López-Olmedo N, De la Cruz-Góngora V, et al. Prevalencia de diabetes y descontrol glucemico en Mexico: Resultados de la Ensanut 2016. Salud Publica Mex. 2020;20;62(1):50-9. https://doi.org/10.21149/10752

  4. World Health Organization. Global report on diabetes [Internet]. Geneva: WHO Library Cataloguing-in-Publication Data, 2016 [cited 2021 May 6]. Available from: https://www.who.int/publications/i/item/9789241565257

  5. International Diabetes Federation. IDF Diabetes Atlas 2019 [Internet]. Brussels: IDF, 2019. Available from: https://diabetesatlas.org/en/resources/

  6. Meza R, Barrientos-Gutierrez T, Rojas-Martinez R, Reynoso-Noverón N, Palacio-Mejia LS, Lazcano-Ponce E, et al. Burden of type 2 diabetes in Mexico: Past, current and future prevalence and incidence rates. Prev Med (Baltim). 2015;81:445-50. https://doi.org/10.1016/j.ypmed.2015.10.015

  7. Aburto TC, Pedraza LS, Sánchez-Pimienta TG, Batis C, Rivera JA. Discretionary foods have a high contribution and fruit, vegetables, and legumes have a low contribution to the total energy intake of the mexican population. J Nutr. 2016;146(9):1881S-1887S. https://doi.org/10.3945/ jn.115.219121

  8. Barquera S, Hernández-Barrera L, Trejo-Valdivia B, Shamah T, Campos- Nonato I, Rivera-Dommarco J. Obesity in Mexico, prevalence and trends in adults. Salud Publica Mex. 2018;62(6):682-92. https://doi. org/10.21149/11630

  9. Medina C, Janssen I, Campos I, Barquera S. Physical inactivity prevalence and trends among Mexican adults: results from the National Health and Nutrition Survey (ENSANUT) 2006 and 2012. BMC Public Health. 2013;13(1):1063. https://doi.org/10.1186/1471-2458-13-1063

  10. Schofield J, Leelarathna L, Thabit H. COVID-19: Impact of and on Diabetes. Diabetes Ther. 2020;11(7):1429-35. https://doi.org/10.1007/ s13300-020-00847-5

  11. Romero-Martínez M, Shamah-Levy T, Vielma-Orozco E, Heredia- Hernández O, Mojica-Cuevas J, Cuevas-Nasu L, et al. National Health and Nutrition Survey 2018-19: Methodology and perspectives. Salud Publica Mex. 2019;61(6):917-23. https://doi.org/10.21149/11095

  12. Romero-Martínez M, Barrientos-Gutiérrez T, Cuevas-Nasu L, Bautista- Arredondo S, Arantxa Colchero M, Gaona-Pineda EB, et al. National Health and Nutrition Survey 2020 Covid-19 methodology. Salud Publica Mex. 2021;63(3):444-51. https://doi.org/10.21149/12580

  13. Centro Nacional de Excelencia Tecnológica en Salud. Diagnóstico y Tratamiento Farmacológico de la Diabetes Mellitus Tipo 2 en el primer nivel de atención. Guía de Referencia Rápida: Guía de Práctica Clínica [Internet]. Mexico City: CENETEC, 2018 [cited 2019 Apr 29]. Available from: http://www.cenetec-difusion.com/CMGPC/GPC-IMSS-718-18/ER.pdf

  14. American Diabetes Association. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S13-28. https://doi.org/10.2337/dc19-S002

  15. Secretaria de Gobernación. Modificación a la Norma Oficial Mexicana NOM-051-SCFI/SSA1-2010, Especificaciones generales de etiquetado para alimentos y bebidas no alcohólicas preenvasados-Información comercial y sanitaria, publicada el 5 de abril de 2010 [Internet]. Mexico City: Secretaria de Economia, 2020. Available from: https://www.dof.gob.mx/2020/ SEECO/NOM_051.pdf

  16. American Diabetes Association. Glycemic Targets: Standards of Medical Care in Diabetes—2019. Diabetes Care. 2019;42(Suppl 1):S61-70. https:// doi.org/10.2337/DC19-S006

  17. World Health Organization. Obesity and overweight factsheet [Internet]. Geneva: WHO, 2021 [cited 2021 Jan 22]. Available from: https://www. who.int/en/news-room/fact-sheets/detail/obesity-and-overweight

  18. Greenland S. Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case-control studies. Am J Epidemiol. 2004;160(4):301-5. https://doi.org/10.1093/aje/ kwh221

  19. Basto-Abreu A, López-Olmedo N, Rojas-Martínez R, Aguilar-Salinas C, De la Cruz-Gongora V, Rivera JA, et al. Appendix 1 to the article “Prevalence of diabetes and glycemic control in Mexico: national results from 2018 and 2020 [Internet]. figshare. 2021 [cited 2021 May 12]. Available from: https://doi.org/10.6084/m9.figshare.14582706.v1

  20. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(Suppl. 1):S81-90. https://doi. org/10.2337/dc14-S081

  21. Lascar N, Brown J, Pattison H, Barnett AH, Bailey CJ, Bellary S. Type 2 diabetes in adolescents and young adults. Lancet Diabetes Endocrinol. 2018;6(1):69-80. https://doi.org/10.1016/S2213-8587(17)30186-9

  22. Flores-Hernández S, Saturno-Hernández PJ, Reyes-Morales H, Barrientos- Gutiérrez T, Villalpando S, Hernández-Ávila M. Quality of diabetes care: The challenges of an increasing epidemic in Mexico. Results from two national health surveys (2006 and 2012). PLoS One. 2015;10(7):e0133958. https://doi.org/10.1371/journal.pone.0133958

  23. Reyes-Morales H, Flores-Hernández S, Sauceda-Valenzuela AL, De Jesús Vértiz-Ramírez J, Juárez-Ramírez C, Wirtz VJ, et al. Users’ perception about quality of ambulatory healthcare services in Mexico. Salud Publica Mex. 2013;55(Suppl. 2):100-5. https://doi.org/10.21149/spm.v55s2.5104

  24. Beltrán-Sánchez H, Drumond-Andrade FC, Riosmena F. Contribution of socioeconomic factors and health care access to the awareness and treatment of diabetes and hypertension among older Mexican adults. Salud Publica Mex. 2015;57(1):S6-14. https://doi.org/10.21149/spm. v57s1.7584

  25. Bellido V, Pérez A. Consequences of COVID-19 on people with diabetes. Endocrinol Diabetes y Nutr. 2020;67(6):355-6. https://doi. org/10.1016/j.endien.2020.04.008




2020     |     www.medigraphic.com